For COVID-19 Detection and Epidemiology, xMAP® Technology Offers Unique Advantages

Multiplex serology tests have yielded impressive results, showing promise for use in the COVID-19 pandemic. xMAP-based serology tests have been widely implemented for the detection of pathogenic bacteria, viruses, and parasites. In the COVID-19 era, xMAP Technology has helped build several new multiplex serology tests designed to detect antibodies to different SARS-CoV-2 antigens. To demonstrate […]

Read More…

How to Reduce Coupling Variability with Luminex Bead Assays

Top 10 tips for a successful coupling process If you’re designing a new multiplex bead-based assay or adding new targets to an existing xMAP® Technology-based assay, the coupling process required to add a protein or an antibody can seem daunting. We’re here to help! While the Luminex custom assay development service can help you with […]

Read More…

xMAP® Technology Users Battle COVID-19 with New Serology Assays

Designed and built by researchers around the world, xMAP® assays shine light on the antibody response to SARS-CoV-2. Our xMAP® Technology empowers researchers to build their own assays quickly, creatively, and effectively. Designed and built by researchers around the world, xMAP® assays shine light on the antibody response to SARS-CoV-2. If you haven’t seen the […]

Read More…

Precision Coupling with Molar Amounts of Protein

Precision coupling is useful for multiplex antibody assays, screening recombinant antibodies, and more! I’ve been getting a lot of requests lately to provide more information on the molar coupling method. If you’ve been wondering how it works, here’s a quick look at how to incorporate molar coupling into your assay development. When coupling whole immunoglobulins […]

Read More…

Considerations Regarding RNA Extraction Kits for SARS-CoV-2 Detection

The novel coronavirus disease (COVID-19) pandemic continues to trigger rapid development of molecular diagnostic tests around the world. Nucleic acid amplification-based tests (NAATs)—such as real-time PCR and isothermal amplification—are the gold standard in molecular diagnostic technologies that are being utilized to detect SARS-CoV-2, the COVID-19 disease-causing virus.1 There are two critical and sequential steps that […]

Read More…

Questions to Ask When Choosing a Multiplex Assay Kit

With the COVID-19 pandemic in full swing, many researchers are looking to multiplex assays to evaluate what they call the “cytokine storm.” This refers to the increase in pro-inflammatory cytokines like IL-6 in patients with COVID-19, which is believed to predict disease severity.1 Many of Luminex’s Partners already have multiplex assays available for research use. […]

Read More…

Webinar: Mouse Model Analysis Is Better with Multiplexing

Query hundreds of immunoassay targets, even with limited sample volume To make the most of immunology-focused assays using the limited tissue and fluid samples available from mouse models, scientists should consider using xMAP® Technology from Luminex, according to Daniel Braunschweig, Proteomics Field Application Scientist Leader at Bio-Rad Laboratories. That’s the takeaway from a 30-minute webinar […]

Read More…

The Versatility of Multiplex Antibody Titer Assays for COVID-19 and Beyond

  The COVID-19 outbreak that began in Wuhan, China in December 2019 was marked by an increase in the number of cases showing pneumonia-like symptoms.1,2 It was not until about a month after the outbreak began that genomic analysis identified a novel coronavirus as the causative agent. With the emergence of new pathogen strains, genomic […]

Read More…